Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px
Document › Details

Sotio a.s.. (2/27/18). "Press Release: Radek Špíšek to Become New CEO of Sotio". Prague.

Organisations Organisation Sotio a.s.
  Group PPF Group (Group)
  Organisation 2 University of Prague (Charles University / Universitas Carolina)
Products Product drug discovery
  Product 2 cancer immunotherapy (immuno-oncology, I-O)
Persons Person Špíšek, Radek (PPF Group 201803– CEO of Sotio + Prof at Charles Univ Prague)
  Person 2 Bartonícek, Ladislav (PPF Group 201502 Board Member responsible for biotechnology)
     


SOTIO, a biotechnology company belonging to the PPF Group, announces today the appointment of Professor Radek Špíšek as Chief Executive Officer. Effective from March 1, 2018, he will replace the current CEO, Ladislav Bartonícek, who will remain active within SOTIO’s top management and will replace Radek Špíšek on the company’s Supervisory Board. The appointment of Radek Špíšek as the CEO will ensure continuity in the company’s management and strategic goals.

Ladislav Bartonícek, who is also a PPF Group shareholder, commented: “Within the span of a few years, SOTIO has been transformed from a small start-up founded on a single product to an international biotechnology company. Today, SOTIO is an integrated company that possesses the necessary capabilities for the research, clinical development, manufacturing and future commercialization of a variety of technologies. New projects launched with partner companies such as Cytune, NBE-Therapeutics, and LDC, are approaching the clinical development stage. Radek’s appointment strengthens the continuity of SOTIO’s strategy and at the same time positions SOTIO well for the development of a broad and diverse pipeline in the near future.”

Ladislav Bartonícek has been SOTIO’s Chief Executive Officer since the beginning of 2014. Radek Špíšek is a co-founder of SOTIO. Since 2010 he has been a member of the company’s top management as well as overseeing research and manufacturing. He has many years of experience in the field of immunotherapy research and clinical development of new cancer therapies.

Radek Špíšek is a graduate of the 1st Medical Faculty of Charles University, and completed postgraduate study in the field of immunology. From 2000 to 2002, he worked at the Institute de Biologie at the University of Nantes in France, followed by three years of research in the team of Ralph Steinmann, a laureate of the Nobel Prize for Physiology or Medicine, at the Department of Tumor Radiology of the Rockefeller University in New York. Radek is a renowned researcher in the field of tumor immunology and antitumor immunotherapy. He is a professor of medical immunology at the 2nd Medical Faculty of Charles University in Prague.

   
Record changed: 2018-03-08

Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October iito 600x60px

More documents for PPF Group (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px




» top